Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells

The eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulation with a ratio of 6:1 is a potent stimulator of the endothelial formation of nitric oxide (NO). The aim of the study was to investigate whether nanoencapsulation of EPA:DHA 6:1 followed by coating with gum increases its biologi...

Full description

Bibliographic Details
Main Authors: L. Remila, E. Belcastro, N. Guenday-Tuereli, S. Park, U. Houngue, T. Vandamme, E. Tuereli, P. Kerth, C. Auger, V. Schini-Kerth
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Journal of Functional Foods
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1756464621005004
_version_ 1818700842226679808
author L. Remila
E. Belcastro
N. Guenday-Tuereli
S. Park
U. Houngue
T. Vandamme
E. Tuereli
P. Kerth
C. Auger
V. Schini-Kerth
author_facet L. Remila
E. Belcastro
N. Guenday-Tuereli
S. Park
U. Houngue
T. Vandamme
E. Tuereli
P. Kerth
C. Auger
V. Schini-Kerth
author_sort L. Remila
collection DOAJ
description The eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulation with a ratio of 6:1 is a potent stimulator of the endothelial formation of nitric oxide (NO). The aim of the study was to investigate whether nanoencapsulation of EPA:DHA 6:1 followed by coating with gum increases its biological activity. Vascular reactivity was assessed using porcine coronary artery rings, the formation of NO in cultured endothelial cells (ECs) using DAF-FM and indirectly by platelet aggregation studies. Coated EPA:DHA 6:1 nanoparticles induced sustained relaxations of coronary artery rings that were greater in rings with than in those without endothelium, and more pronounced than with the native form. Treatment of ECs with coated EPA:DHA 6:1 nanoparticles caused greater and more sustained formation of NO and enhanced their anti-aggregatory effects. Thus, nanoencapsulation of EPA:DHA 6:1 is an attractive strategy to enhance the beneficial effect at the vascular endothelium.
first_indexed 2024-12-17T15:11:22Z
format Article
id doaj.art-2347271eb122473e919adf113b841730
institution Directory Open Access Journal
issn 1756-4646
language English
last_indexed 2024-12-17T15:11:22Z
publishDate 2021-12-01
publisher Elsevier
record_format Article
series Journal of Functional Foods
spelling doaj.art-2347271eb122473e919adf113b8417302022-12-21T21:43:39ZengElsevierJournal of Functional Foods1756-46462021-12-0187104851Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cellsL. Remila0E. Belcastro1N. Guenday-Tuereli2S. Park3U. Houngue4T. Vandamme5E. Tuereli6P. Kerth7C. Auger8V. Schini-Kerth9University of Strasbourg, INSERM UMR 1260, Regenerative Nanomedicine, Strasbourg, FranceUniversity of Strasbourg, INSERM UMR 1260, Regenerative Nanomedicine, Strasbourg, FranceMyBiotech GmbH, Ueberherrn, GermanyUniversity of Strasbourg, INSERM UMR 1260, Regenerative Nanomedicine, Strasbourg, FranceUniversity of Strasbourg, INSERM UMR 1260, Regenerative Nanomedicine, Strasbourg, FranceUniversity of Strasbourg, INSERM UMR 1260, Regenerative Nanomedicine, Strasbourg, FranceMyBiotech GmbH, Ueberherrn, GermanyPreventor TBC GmbH, Pfungstadt, GermanyUniversity of Strasbourg, INSERM UMR 1260, Regenerative Nanomedicine, Strasbourg, FranceUniversity of Strasbourg, INSERM UMR 1260, Regenerative Nanomedicine, Strasbourg, France; Corresponding author at: INSERM UMR 1260, Faculty of Pharmacy, University of Strasbourg, 1, rue Eugène Boeckel, 67084 Strasbourg, France.The eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) formulation with a ratio of 6:1 is a potent stimulator of the endothelial formation of nitric oxide (NO). The aim of the study was to investigate whether nanoencapsulation of EPA:DHA 6:1 followed by coating with gum increases its biological activity. Vascular reactivity was assessed using porcine coronary artery rings, the formation of NO in cultured endothelial cells (ECs) using DAF-FM and indirectly by platelet aggregation studies. Coated EPA:DHA 6:1 nanoparticles induced sustained relaxations of coronary artery rings that were greater in rings with than in those without endothelium, and more pronounced than with the native form. Treatment of ECs with coated EPA:DHA 6:1 nanoparticles caused greater and more sustained formation of NO and enhanced their anti-aggregatory effects. Thus, nanoencapsulation of EPA:DHA 6:1 is an attractive strategy to enhance the beneficial effect at the vascular endothelium.http://www.sciencedirect.com/science/article/pii/S1756464621005004Omega-3NanoencapsulationEPA:DHA 6:1EndotheliumNitric oxide
spellingShingle L. Remila
E. Belcastro
N. Guenday-Tuereli
S. Park
U. Houngue
T. Vandamme
E. Tuereli
P. Kerth
C. Auger
V. Schini-Kerth
Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells
Journal of Functional Foods
Omega-3
Nanoencapsulation
EPA:DHA 6:1
Endothelium
Nitric oxide
title Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells
title_full Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells
title_fullStr Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells
title_full_unstemmed Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells
title_short Nanoencapsulation of the omega-3 EPA:DHA 6:1 formulation enhances and sustains NO-mediated endothelium-dependent relaxations in coronary artery rings and NO formation in endothelial cells
title_sort nanoencapsulation of the omega 3 epa dha 6 1 formulation enhances and sustains no mediated endothelium dependent relaxations in coronary artery rings and no formation in endothelial cells
topic Omega-3
Nanoencapsulation
EPA:DHA 6:1
Endothelium
Nitric oxide
url http://www.sciencedirect.com/science/article/pii/S1756464621005004
work_keys_str_mv AT lremila nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT ebelcastro nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT nguendaytuereli nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT spark nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT uhoungue nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT tvandamme nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT etuereli nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT pkerth nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT cauger nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells
AT vschinikerth nanoencapsulationoftheomega3epadha61formulationenhancesandsustainsnomediatedendotheliumdependentrelaxationsincoronaryarteryringsandnoformationinendothelialcells